Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
coronaries
100%
netherlands
100%
design
100%
interventions
100%
data
40%
patients
30%
medicine
20%
pharmaceuticals
20%
laboratories
10%
values
10%
risks
10%
reviews
10%
diabetes mellitus
10%
populations
10%
guidelines
10%
management
10%
ischemia
10%
cholesterol
10%
stratification
10%
Keyphrases
Percutaneous Coronary Intervention
100%
Secondary Prevention
66%
Personalized Medicine
22%
Medication Changes
22%
Pharmaceutical Therapy
22%
Diabetes Mellitus
11%
Comorbidity
11%
Adverse Events
11%
Patient-reported Outcomes
11%
Bleeding Events
11%
Risk Stratification
11%
Personalized Treatment
11%
Thromboembolic Complications
11%
Antiplatelet Therapy
11%
Bleeding Complications
11%
Laboratory Values
11%
Referral Center
11%
Multicenter Registry
11%
Clinical Event Committee
11%
Post-percutaneous Coronary Intervention
11%
Antiplatelet Strategy
11%
Ischemic Events
11%
Simplified Protocol
11%
Procedural Characteristics
11%
Prospective multicenter
11%
Consecutive Patients
11%
Follow-up Data
11%
Treatment Data
11%
Cholesterol Control
11%
Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Secondary Prevention
60%
Drug Therapy
20%
Personalized Medicine
20%
Antiplatelet
20%
Diabetes Mellitus
10%
Patient Referral
10%
Risk Stratification
10%
Bleeding
10%
Weakness
10%
Thromboembolism
10%
Cholesterol
10%
Comorbidity
10%
Patient-Reported Outcome
10%
Adverse Event
10%